JNJ insider transaction filings
JOHNSON & JOHNSON — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-18. Screen JNJ transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-18 | 4 | Taubert Jennifer L — EVP, WWC. Innovative Medicine | Option exercise (M): 15,000 @ $115.67 · Sale (S): 15,000 @ $263.36 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2026-08-14 | 4 | Duato Joaquin — CEO and Chairman of the Board, Director | Option exercise (M): 123,291 @ $115.67 · Sale (S): 20,976 @ $262 · Sale (S): 102,315 @ $261 · Option exercise (M): 123,291 (derivative) @ $0 | EDGAR |
| 2026-08-07 | 4 | Duato Joaquin — CEO and Chairman of the Board, Director | Sale (S): 41,957 @ $258.06 · Sale (S): 6,523 @ $258.74 | EDGAR |
| 2026-08-07 | 4 | Forminard Elizabeth — EVP, Chief Legal Officer | Option exercise (M): 9,344 @ $131.94 · Sale (S): 9,344 @ $257.75 · Sale (S): 6,574 @ $255.93 · Option exercise (M): 9,344 (derivative) @ $0 | EDGAR |
| 2026-07-21 | 4 | Broadhurst Vanessa — EVP, Global Corp Affairs | Option exercise (M): 11,129 @ $129.51 · Option exercise (M): 11,925 @ $131.94 · Sale (S): 23,054 @ $251.27 · Option exercise (M): 11,129 (derivative) @ $0 · Option exercise (M): 11,925 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | Wengel Kathryn E — EVP, Chief TO and Risk Officer | Option exercise (M): 10,000 @ $115.67 · Sale (S): 10,000 @ $241.15 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2026-06-11 | 4 | Woods Eugene A. — Director | Grant/award (A): 161.09 (derivative) @ $232.79 | EDGAR |
| 2026-06-11 | 4 | Pinto Daniel E — Director | Grant/award (A): 134.24 (derivative) @ $232.79 | EDGAR |
| 2026-06-11 | 4 | HEWSON MARILLYN A — Director | Grant/award (A): 214.79 (derivative) @ $232.79 | EDGAR |
| 2026-05-04 | 4 | REED JOHN C — EVP, Innovative Medicine, R&D | Option exercise (M): 25,255 @ $0 · Tax withholding (F): 11,002 @ $229.85 · Option exercise (M): 25,255 (derivative) @ $0 | EDGAR |
| 2026-04-27 | 4 | West Nadja — Director | Grant/award (A): 975 (derivative) @ $0 | EDGAR |
| 2026-04-27 | 4 | WEINBERGER MARK A — Director | Grant/award (A): 975 (derivative) @ $0 | EDGAR |
| 2026-04-27 | 4 | Woods Eugene A. — Director | Grant/award (A): 975 (derivative) @ $0 | EDGAR |
| 2026-04-27 | 4 | Doudna Jennifer A — Director | Grant/award (A): 975 (derivative) @ $0 | EDGAR |
| 2026-04-27 | 4 | McClellan Mark B. — Director | Grant/award (A): 975 (derivative) @ $0 | EDGAR |
| 2026-04-27 | 4 | Pinto Daniel E — Director | Grant/award (A): 1,712 (derivative) @ $0 | EDGAR |
| 2026-04-27 | 4 | Beckerle Mary C — Director | Grant/award (A): 975 (derivative) @ $0 | EDGAR |
| 2026-04-27 | 4 | Joly Hubert — Director | Grant/award (A): 975 (derivative) @ $0 | EDGAR |
| 2026-04-27 | 4 | Johnson Paula A — Director | Grant/award (A): 975 (derivative) @ $0 | EDGAR |
| 2026-04-27 | 4 | HEWSON MARILLYN A — Director | Grant/award (A): 975 (derivative) @ $0 | EDGAR |
| 2026-04-27 | 4 | MORIKIS JOHN G — Director | Grant/award (A): 1,540 (derivative) @ $0 | EDGAR |
| 2026-03-12 | 4 | Woods Eugene A. — Director | Grant/award (A): 154.87 (derivative) @ $242.14 | EDGAR |
| 2026-03-12 | 4 | Pinto Daniel E — Director | Grant/award (A): 129.06 (derivative) @ $242.14 | EDGAR |
| 2026-03-12 | 4 | HEWSON MARILLYN A — Director | Grant/award (A): 75.26 (derivative) @ $166.10 · Grant/award (A): 206.49 (derivative) @ $242.14 | EDGAR |
| 2026-03-03 | 4 | Decker Robert J — VP Corporate Controller | Option exercise (M): 4,075 @ $115.67 · Sale (S): 4,075 @ $247.87 · Option exercise (M): 4,075 (derivative) @ $0 | EDGAR |
| 2026-02-23 | 4 | Schmid Timothy — EVP, WW Chair, MedTech | Sale (S): 1,322 @ $245.66 | EDGAR |
| 2026-02-18 | 4 | Mulholland Kristen — EVP, Chief HR Officer | Option exercise (M): 410 @ $0 · Tax withholding (F): 135 @ $244.55 · Option exercise (M): 3,602 @ $0 · Tax withholding (F): 1,027 @ $244.55 · Option exercise (M): 419 @ $0 · Tax withholding (F): 172 @ $243.45 · +8 more | EDGAR |
| 2026-02-18 | 4 | Schmid Timothy — EVP, WW Chair, MedTech | Option exercise (M): 499 @ $0 · Tax withholding (F): 8 @ $244.55 · Option exercise (M): 4,378 @ $0 · Tax withholding (F): 1,816 @ $244.55 · Option exercise (M): 1,028 @ $0 · Tax withholding (F): 15 @ $243.45 · +14 more | EDGAR |
| 2026-02-18 | 4 | Forminard Elizabeth — EVP, Chief Legal Officer | Option exercise (M): 651 @ $0 · Tax withholding (F): 314 @ $244.55 · Option exercise (M): 13,706 @ $0 · Tax withholding (F): 7,011 @ $244.55 · Option exercise (M): 961 @ $0 · Tax withholding (F): 492 @ $243.45 · +8 more | EDGAR |
| 2026-02-18 | 4 | Broadhurst Vanessa — EVP, Global Corp Affairs | Option exercise (M): 408 @ $0 · Tax withholding (F): 144 @ $244.55 · Option exercise (M): 8,594 @ $0 · Tax withholding (F): 3,748 @ $244.55 · Option exercise (M): 492 @ $0 · Tax withholding (F): 252 @ $243.45 · +9 more | EDGAR |
| 2026-02-18 | 4 | Swanson James D. — EVP, CIO | Option exercise (M): 447 @ $0 · Tax withholding (F): 143 @ $244.55 · Option exercise (M): 9,412 @ $0 · Tax withholding (F): 3,547 @ $244.55 · Option exercise (M): 19,368 @ $165.89 · Sale (S): 19,368 @ $243.76 · +17 more | EDGAR |
| 2026-02-18 | 4 | Decker Robert J — VP Corporate Controller | Option exercise (M): 312 @ $0 · Tax withholding (F): 104 @ $244.55 · Option exercise (M): 2,741 @ $0 · Tax withholding (F): 762 @ $244.55 · Option exercise (M): 339 @ $0 · Tax withholding (F): 94 @ $243.45 · +8 more | EDGAR |
| 2026-02-18 | 4 | Wengel Kathryn E — EVP, Chief TO and Risk Officer | Option exercise (M): 651 @ $0 · Tax withholding (F): 217 @ $244.55 · Option exercise (M): 13,706 @ $0 · Tax withholding (F): 6,414 @ $244.55 · Option exercise (M): 606 @ $0 · Tax withholding (F): 310 @ $243.45 · +8 more | EDGAR |
| 2026-02-18 | 4 | Taubert Jennifer L — EVP, WWC. Innovative Medicine | Option exercise (M): 1,302 @ $0 · Tax withholding (F): 409 @ $244.55 · Option exercise (M): 27,412 @ $0 · Tax withholding (F): 13,547 @ $244.55 · Option exercise (M): 1,594 @ $0 · Tax withholding (F): 816 @ $243.45 · +8 more | EDGAR |
| 2026-02-18 | 4 | Wolk Joseph J — Exec VP, CFO | Option exercise (M): 37,463 @ $0 · Tax withholding (F): 15,948 @ $244.55 · Option exercise (M): 1,779 @ $0 · Tax withholding (F): 507 @ $244.55 · Option exercise (M): 1,971 @ $0 · Tax withholding (F): 858 @ $243.45 · +18 more | EDGAR |
| 2026-02-18 | 4 | Duato Joaquin — CEO and Chairman of the Board, Director | Option exercise (M): 3,469 @ $0 · Tax withholding (F): 989 @ $244.55 · Option exercise (M): 73,054 @ $0 · Tax withholding (F): 31,679 @ $244.55 · Option exercise (M): 3,682 @ $0 · Tax withholding (F): 1,602 @ $243.45 · +8 more | EDGAR |
| 2026-02-18 | 4 | REED JOHN C — EVP, Innovative Medicine, R&D | Option exercise (M): 1,349 @ $0 · Tax withholding (F): 385 @ $243.45 · Option exercise (M): 1,847 @ $0 · Tax withholding (F): 528 @ $243.45 · Option exercise (M): 21,721 @ $157.92 · Sale (S): 21,721 @ $243 · +9 more | EDGAR |
| 2026-02-11 | 4 | Mulholland Kristen — EVP, Chief HR Officer | Grant/award (A): 3,602 (derivative) @ $0 | EDGAR |
| 2026-02-11 | 4 | Schmid Timothy — EVP, WW Chair, MedTech | Grant/award (A): 4,378 (derivative) @ $0 | EDGAR |
| 2026-02-11 | 4 | Forminard Elizabeth — EVP, Chief Legal Officer | Grant/award (A): 13,706 (derivative) @ $0 | EDGAR |
| 2026-02-11 | 4 | Broadhurst Vanessa — EVP, Global Corp Affairs | Grant/award (A): 8,594 (derivative) @ $0 | EDGAR |
| 2026-02-11 | 4 | Swanson James D. — EVP, CIO | Grant/award (A): 9,412 (derivative) @ $0 | EDGAR |
| 2026-02-11 | 4 | Decker Robert J — VP Corporate Controller | Grant/award (A): 2,741 (derivative) @ $0 | EDGAR |
| 2026-02-11 | 4 | Wengel Kathryn E — EVP, Chief TO and Risk Officer | Grant/award (A): 13,706 (derivative) @ $0 | EDGAR |
| 2026-02-11 | 4 | Taubert Jennifer L — EVP, WWC. Innovative Medicine | Grant/award (A): 27,412 (derivative) @ $0 | EDGAR |
| 2026-02-11 | 4 | Wolk Joseph J — Exec VP, CFO | Grant/award (A): 37,463 (derivative) @ $0 | EDGAR |
| 2026-02-11 | 4 | Duato Joaquin — CEO and Chairman of the Board, Director | Grant/award (A): 73,054 (derivative) @ $0 | EDGAR |
| 2026-02-10 | 4 | Schmid Timothy — EVP, WW Chair, MedTech | Option exercise (M): 15,571 @ $101.87 · Tax withholding (F): 10,335 @ $239.99 · Option exercise (M): 15,571 (derivative) @ $101.87 | EDGAR |
| 2026-02-09 | 4 | Mulholland Kristen — EVP, Chief HR Officer | Option exercise (M): 5,625 @ $101.87 · Tax withholding (F): 3,335 @ $239.99 · Option exercise (M): 5,625 (derivative) @ $101.87 | EDGAR |
| 2026-02-09 | 4 | Wengel Kathryn E — EVP, Chief TO and Risk Officer | Option exercise (M): 38,945 @ $101.87 · Tax withholding (F): 27,270 @ $239.99 · Option exercise (M): 38,945 (derivative) @ $101.87 | EDGAR |
Recent 8-K events — JOHNSON & JOHNSON
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-04 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-29 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-28 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-15 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-28 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-14 | 8-K | 2.02 — Results of Operations and Financial Condition 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-21 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-14 | 8-K | 2.02 — Results of Operations and Financial Condition 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-09-09 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2025-07-16 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=JNJ returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →